查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1649523

全球羥氯喹藥物市場預測（2025-2030）

Global Hydroxychloroquine Drugs Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

羥氯喹藥品市場預計將從 2025 年的 11.74 億美元成長到 2030 年的 13.36 億美元，複合年成長率為 2.62%。

羥氯喹是抗瘧疾藥，常用於治療瘧疾和類風濕性關節炎、紅斑性狼瘡等自體免疫疾病。羥氯喹可減輕發炎並調節免疫系統，從而預防自體免疫疾病發作並抑制瘧原蟲的生長。整體而言，羥氯喹的副作用較小，但偶爾會引起胃腸道刺激和皮疹，長期使用可能會導致視網膜損傷。羥氯喹在新冠疫情期間引起了廣泛關注，但其有效性僅在有限的臨床試驗中得到證實。雖然它仍然是治療各種慢性病的有效選擇，但由於長期使用可能產生副作用，因此必須仔細監測。

推動全球羥氯喹市場的因素

  • 慢性病發病率上升：類風濕性關節炎、紅斑性狼瘡和瘧疾等慢性病發病率上升推動了對羥氯喹的需求。世界衛生組織 (WHO) 已發現 150 多種風濕性或肌肉骨骼疾病可導致不同程度的疼痛和殘疾。類風濕性關節炎影響約 0.1% 至 0.3% 的人口，主要影響已開發國家的女性。

瘧疾仍然是世界上最受歡迎的疾病之一，羥氯喹可以有效治療瘧疾。根據《2024年世界瘧疾報告》，預計2023年全球將有2.63億人罹患瘧疾，較前一年增加。當年死亡人數約59.7萬。

地理見解

全球羥氯喹市場分為五個地區：北美、南美、歐洲、中東和非洲、亞太地區。

  • 北美：羥氯喹市場主要受類風濕性關節炎和狼瘡等自體免疫疾病高發生率的推動。認知的提高和診斷能力的提高進一步推動了需求。發達的醫療基礎設施使人們能夠輕鬆獲得羥氯喹，同時正在進行的研究正在探索該藥物的新用途。
  • 亞太地區：在該地區，羥氯喹的需求受到瘧疾高發病率的影響，尤其是在印度、印尼和菲律賓等國家，羥氯奎在瘧疾預防和治療策略中發揮關鍵作用。

總而言之，由於慢性病和瘧疾盛行率的上升，以及各地區醫療保健基礎設施意識的不斷提高和進步，全球羥氯喹市場預計將成長。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 各地區（包括細分市場和國家）的收益成長和預測分析
  • 公司概況（策略、產品、財務、主要發展等）

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析

第5章 全球羥氯喹藥物市場（依應用）

  • 介紹
  • 類風濕性關節炎
  • 瘧疾
  • 其他

第6章 全球羥氯喹藥物市場（依最終用戶）

  • 介紹
  • 醫院和診所
  • 門診手術中心
  • 實驗室

第 7 章 全球羥氯喹藥物市場（按地區）

  • 世界概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他亞太地區

第8章 競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第9章 公司簡介

  • Novartis AG
  • Sanofi
  • Amneal Pharmaceuticals LLC.
  • Dr. Reddy's Laboratories
  • McKesson Medical-Surgical Inc.
  • Laurus Labs Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Mylan NV
  • Apotex
簡介目錄
Product Code: KSI061613621

The global hydroxychloroquine drugs market is projected to grow at a CAGR of 2.62%, from US$1.174 billion in 2025 to US$1.336 billion in 2030.

Hydroxychloroquine is an antimalarial medication commonly used to treat malaria, as well as autoimmune diseases such as rheumatoid arthritis and lupus. It works by inhibiting inflammation and regulating the immune system, which helps reduce flare-ups of autoimmune disorders and suppresses the growth of the malaria parasite. Overall, hydroxychloroquine has a favorable side effect profile; however, it can occasionally cause gastrointestinal irritation and skin rashes, with chronic use potentially leading to retinal damage. The drug gained significant attention during the COVID-19 pandemic, although its effectiveness for this purpose has only been supported by a few limited clinical trials. While it remains a valuable option for managing various chronic conditions, careful monitoring is essential due to possible adverse effects associated with long-term use.

Drivers of the Global Hydroxychloroquine Market:

  • Increasing Prevalence of Chronic Conditions: The demand for hydroxychloroquine is being driven by the rising incidence of chronic conditions such as rheumatoid arthritis, lupus, and malaria. The World Health Organization (WHO) identifies over 150 rheumatic or musculoskeletal diseases that can cause varying levels of pain and disability. Rheumatoid arthritis affects approximately 0.1% to 0.3% of the population, predominantly women in developed countries, typically between the ages of 20 and 40.

Malaria remains one of the most widespread diseases globally, treated effectively with hydroxychloroquine. According to the World Malaria Report 2024, there were an estimated 263 million cases of malaria worldwide in 2023, marking an increase from previous years. In that same year, approximately 597,000 deaths were attributed to malaria.

Geographical Insights:

The global hydroxychloroquine market is segmented into five regions: North America, South America, Europe, the Middle East & Africa, and Asia-Pacific.

  • North America: The hydroxychloroquine market in North America is primarily driven by a high prevalence of autoimmune diseases such as rheumatoid arthritis and lupus that require long-term management with this medication. Increased awareness and improved diagnostic capabilities further enhance demand. The advanced healthcare infrastructure ensures easy access to hydroxychloroquine, while ongoing research explores new applications for the drug.
  • Asia-Pacific: In this region, demand for hydroxychloroquine is largely influenced by a high burden of malaria, particularly in countries like India, Indonesia, and the Philippines where it plays a crucial role in malaria prevention and treatment strategies.

In summary, the global hydroxychloroquine market is expected to grow due to rising rates of chronic diseases and malaria, alongside increased awareness and advancements in healthcare infrastructure across various regions.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The global Hydroxychloroquine drugs market is segmented and analyzed as follows:

By Application

  • Rheumatoid Arthritis
  • Malaria
  • Others

By End-User

  • Hospitals and Clinics
  • Ambulatory Surgical Centres
  • Research Labs

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Rest of the Middle East and Africa
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Rheumatoid Arthritis
  • 5.3. Malaria
  • 5.4. Others

6. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Ambulatory Surgical Centres
  • 6.4. Research Labs

7. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY GEOGRAPHY

  • 7.1. Global Overview
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Rest of South America
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Rest of Europe
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. United Arab Emirates
    • 7.5.3. Rest of Middle East and Africa
  • 7.6. Asia-Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Rest of Asia-Pacific

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Novartis AG
  • 9.2. Sanofi
  • 9.3. Amneal Pharmaceuticals LLC.
  • 9.4. Dr. Reddy's Laboratories
  • 9.5. McKesson Medical-Surgical Inc.
  • 9.6. Laurus Labs Ltd.
  • 9.7. Lupin Pharmaceuticals, Inc.
  • 9.8. Mylan N.V.
  • 9.9. Apotex